Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Osiris Therapeutics, Inc. (OSIR)

« Back to company index

OSIR Chatter Timeline

Stock Ticker for OSIR

Most Active Tweeters for OSIR

UserTweets
@biotechfan20 12
@StockTexts 2
@filing_scanner 2
@rc08610 2
@UnknownPatriot7 2

Recent Tweets for OSIR

UnknownPatriot7 @UnknownPatriot7
@DMOptions Re: Delist, the wildcard is the SEC. Took them one year (almost to the day) to delist $OSIR to pinks. W… https://t.co/QxRhAdkec9
July 15th 2018, 11:07pm
biotechfan20 @biotechfan20
$osir products work. https://t.co/eQUKz2PM0W
July 15th 2018, 4:07pm
UnknownPatriot7 @UnknownPatriot7
@stagnantshares Why don’t you just look at $OSIR for cost and duration. A direct product competitor with a similar restatement period.??
July 14th 2018, 10:07pm
biotechfan20 @biotechfan20
If the number of trademarks is representative of the market outlook on $osir latest innovation, it looks promising… https://t.co/No7Xo5ww7N
July 13th 2018, 10:07am
biotechfan20 @biotechfan20
More rigorous science from $OSIR https://t.co/Qvdf3nAKwi $MDXG
July 12th 2018, 8:07am
rc08610 @rc08610
@stagnantshares Don’t forget the cash for shareholders class action settlement. $OSIR settled at $18.5M. Any guesse… https://t.co/GbJZifTDCH
July 12th 2018, 7:07am
StockNewsNow @StockNewsNow
$OSIR Osiris Announces Enrollment of Patients in a Clinical Trial Evaluating GrafixPL PRIME™ in the Treatment of Ch… https://t.co/XW4Ub49Db0
July 11th 2018, 5:07pm
MarketCurrents @MarketCurrents
Osiris launches study of GrafixPL PRIME in venous leg ulcers https://t.co/7H9TymgZf8 $OSIR
July 11th 2018, 4:07pm
StockWolfCom @StockWolfCom
$OSIR Osiris Announces Enrollment of Patients in a Clinical Trial Evaluating GrafixPL PRIME™ in the Treatment of Ch… https://t.co/sFy7l61Gc9
July 11th 2018, 4:07pm
GNWLive @GNWLive
Osiris Announces Enrollment of Patients in a Clinical Trial Evaluating GrafixPL PRIME™ in the Treatment of $OSIR https://t.co/66uw8o5WVz
July 11th 2018, 4:07pm
StockTexts @StockTexts
$OSIR Osiris Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/5kfaTcMNph
July 10th 2018, 5:07pm
filing_scanner @filing_scanner
$OSIR New Insider Filing On: VENTURETEC INC Transaction Code: J https://t.co/4SseaalWtb
July 10th 2018, 1:07pm
rc08610 @rc08610
@confcalltran Transferred all shares back to Swiss parent company. $OSIR
July 10th 2018, 9:07am
filing_scanner @filing_scanner
$OSIR New Insider Filing On: VENTURETEC INC Transaction Code: J https://t.co/4Sseaa4l4B
July 10th 2018, 12:07am
InsiderAlertsIA @InsiderAlertsIA
$OSIR: New Insider Filing on 10%+ Owner VENTURETEC INC: https://t.co/8TgzNngfVY
July 9th 2018, 4:07pm
StockTexts @StockTexts
$OSIR Osiris Therapeutics, Inc. SEC Filing: Form 4 https://t.co/LzeBRbMwIm
July 9th 2018, 4:07pm
DonutShorts @DonutShorts
RT @biotechfan20: Complete wound closure 63% for $OSIR Grafix in contrast with 18% for $MDXG Epifix Journal of Wound Repair & Regeneration…
July 6th 2018, 7:07pm
biotechfan20 @biotechfan20
Complete wound closure 63% for $OSIR Grafix in contrast with 18% for $MDXG Epifix Journal of Wound Repair & Regener… https://t.co/f6NoFlIi1y
July 6th 2018, 6:07pm
biotechfan20 @biotechfan20
$OSIR 100% Bullish the Blogger sentiment is more Bullish than other stocks in the Healthcare sector. https://t.co/2hx4ls7AnK
July 5th 2018, 3:07pm
biotechfan20 @biotechfan20
$OSIR Grafix works https://t.co/LPTlrADTkT #diabetic #DFU
July 5th 2018, 2:07pm
biotechfan20 @biotechfan20
More unbiased evidence that $OSIR Grafix works -- https://t.co/UwsucrABSX
July 5th 2018, 9:07am
biotechfan20 @biotechfan20
$OSIR Stravix shows promise as a novel adjunct to support endometrial regeneration following laparoscopic myomectom… https://t.co/ISQ3LRwx91
July 4th 2018, 11:07am
biotechfan20 @biotechfan20
Things must be going well at Osiris Therapeutics! Jason Keefer $OSIR Interim President and Chief Executive Officer… https://t.co/e2Z5DlqSUv
July 2nd 2018, 8:07pm
confcalltran @confcalltran
Entry into a Material Definitive https://t.co/UQL9KK0oIW $OSIR
July 2nd 2018, 4:07pm
biotechfan20 @biotechfan20
$OSIR please prepare to receive another milestone payment from $MESO https://t.co/HYdkkm4ZGl
July 2nd 2018, 1:07pm
biotechfan20 @biotechfan20
In contrast, National Institute for Health and Care Excellence in UK described $OSIR Grafix study as "high quality… https://t.co/HtM3hldpfu
July 2nd 2018, 11:07am
biotechfan20 @biotechfan20
$OSIR Grafix demonstrates positive outcomes in patients typically excluded from clinical research due to the severi… https://t.co/EqHMNIbrxF
July 2nd 2018, 10:07am
Allstocknews @Allstocknews
$OSIR New Form 4 for Osiris Therapeutics, Inc. From our Stock News Alerts App
June 28th 2018, 4:06pm
InsiderAlertsIA @InsiderAlertsIA
$OSIR: New Insider Filing on Interim President and CEO JASON KEEFER: https://t.co/gnVOYItqWr
June 28th 2018, 4:06pm
StockTexts @StockTexts
$OSIR Osiris Therapeutics, Inc. SEC Filing: Form 4 https://t.co/WW9drRovNB
June 28th 2018, 4:06pm
biotechfan20 @biotechfan20
At todays annual meeting $OSIR stated that they have applied for relisting on #NASDAQ
June 26th 2018, 2:06pm
UnknownPatriot7 @UnknownPatriot7
@AlderLaneeggs once did a Periscope on $OSIR & $MDXG. https://t.co/dIDvkL7haW
June 15th 2018, 12:06pm
biotechfan20 @biotechfan20
$OSIR shows 398 employees on Linkedin. Sales personnel headcount up 22% That reflects significant growth.
June 15th 2018, 10:06am
biotechfan20 @biotechfan20
@AlderLaneeggs I hope $OSIR lawsuit against $MDXG is resolved and paid before that!
June 14th 2018, 12:06pm
Raymcgillicuddy @Raymcgillicuddy
@AlderLaneeggs you have previously said you have proof $mdxg kneecapped $OSIR... do you mind expanding on your comm… https://t.co/QSZs0DacRl
June 12th 2018, 8:06am
70deadend @70deadend
@AlderLaneeggs $OSIR fraud was willful and intentional. Come on. They hired Todd Clawson to oversee sales to VA. Pe… https://t.co/XAk45t5ZJP
June 10th 2018, 11:06am
WeekHerald @WeekHerald
Osiris Therapeutics $OSIR Lifted to “Buy” at ValuEngine https://t.co/aoxnKAkvhr
June 9th 2018, 6:06am
registrarjourn @registrarjourn
Osiris Therapeutics $OSIR Stock Rating Upgraded by ValuEngine https://t.co/FIQeOkM4Ty
June 8th 2018, 6:06am
dakotafinancial @dakotafinancial
Osiris Therapeutics $OSIR Stock Rating Upgraded by ValuEngine https://t.co/mwUIFEHjLV
June 8th 2018, 2:06am
ledgerzette @ledgerzette
Osiris Therapeutics $OSIR Upgraded by ValuEngine to “Buy” https://t.co/wks2Xsnddr
June 6th 2018, 10:06pm
midetimes @midetimes
Osiris Therapeutics $OSIR Upgraded by ValuEngine to “Buy” https://t.co/7AagH4ezcz #stocks
June 6th 2018, 10:06pm
TickerReport @TickerReport
Osiris Therapeutics $OSIR Upgraded by ValuEngine to “Buy” https://t.co/SUefgTxckC
June 6th 2018, 10:06pm
dailypoliticaln @dailypoliticaln
Osiris Therapeutics $OSIR Upgraded by ValuEngine to “Buy” https://t.co/26DsSNfWFc
June 6th 2018, 10:06pm
biotechfan20 @biotechfan20
June 4 $OSIR 8K announced validation, testing, & scale up of Prestige Lyotechnology(PL) to manufacture ambient stor… https://t.co/MUzzCaJmjQ
June 6th 2018, 1:06pm
biotechfan20 @biotechfan20
if $SCOR can relist on NASDAQ the day after annual meeting, so can $OSIR
June 6th 2018, 1:06pm
biotechfan20 @biotechfan20
$OSIR Grafix demonstrates positive outcomes in patients typically excluded from clinical research due to the severi… https://t.co/1TfMTEeJAL
June 6th 2018, 1:06pm
otcdynamics @otcdynamics
$OSIR Osiris Announces Implementation of Prestige Lyotechnology? Preservation Method Allowing Ambient Storage of https://t.co/kGmLAkDwNz
June 4th 2018, 4:06pm
biotechfan20 @biotechfan20
June 04, 2018 $OSIR announced today the implementation of Prestige Lyotechnology for manufacturing of commercial pr… https://t.co/zrfSo3HrFm
June 4th 2018, 4:06pm
StockWolfCom @StockWolfCom
$OSIR Osiris Announces Implementation of Prestige Lyotechnology? Preservation Method Allowing Ambient Storage of Li… https://t.co/ixZd0WHwXv
June 4th 2018, 4:06pm
livetraderalrt @livetraderalrt
$OSIR 1.4m ago: Current event(s) report - Other Events, Financial Statements and Exhibits https://t.co/wjr5BxsUjZ
June 4th 2018, 4:06pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.